ELEVEN BIOTHERAPEUTICS INC - COM (EBIO)

CUSIP: 286221106

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM
Total 13F shares
1,218,710
Share change
+87,798
Total reported value
$1,926,000
Price per share
$1.58
Number of holders
17
Value change
+$142,016
Number of buys
3
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 286221106?
CUSIP 286221106 identifies EBIO - ELEVEN BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ELEVEN BIOTHERAPEUTICS INC - COM (EBIO) as of Q3 2017

As of 30 Sep 2017, ELEVEN BIOTHERAPEUTICS INC - COM (EBIO) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,218,710 shares. The largest 10 holders included BlackRock Inc., Municipal Employees' Retirement System of Michigan, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Bank of New York Mellon Corp, Virtu Financial LLC, CITADEL ADVISORS LLC, and NORTHERN TRUST CORP. This page lists 17 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.